0000899243-17-024530.txt : 20171019
0000899243-17-024530.hdr.sgml : 20171019
20171019202940
ACCESSION NUMBER: 0000899243-17-024530
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171012
FILED AS OF DATE: 20171019
DATE AS OF CHANGE: 20171019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALDRICH RICHARD
CENTRAL INDEX KEY: 0001185039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 171145786
MAIL ADDRESS:
STREET 1: 1365 MAIN STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200915291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (857) 999-0075
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Therapeutics, Inc.
DATE OF NAME CHANGE: 20140916
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery, Inc
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery Inc
DATE OF NAME CHANGE: 20060105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-12
0
0001348911
KalVista Pharmaceuticals, Inc.
KALV
0001185039
ALDRICH RICHARD
C/O LONGWOOD CAPITAL
PRUDENTIAL TOWER, 800 BOYLSTON STREET, S
BOSTON
MA
02199
1
0
0
0
Common Stock
2017-10-12
4
P
0
565065
8.6131
A
934484
I
See Footnote
The reportable securities are owned directly by Longwood Fund II, LP, a Delaware limited partnership ("Longwood II"). Longwood Fund II GP, LLC, a Delaware limited liability company ("Longwood II GP"), is the general partner of Longwood II and exercises voting and investment power with respect to the securities owned directly by Longwood II. Longwood II's investment adviser is Longwood Fund Management, LLC ("Longwood Management"). Each of the Reporting Person, who is a member of the Issuer's board of directors, and Christoph Westphal, M.D., Ph.D. ("Westphal") are the Managers (and are members) of Longwood II GP and may be deemed to share voting and investment power with respect to the securities owned by Longwood II.
(Continue from footnote 1) Each of the Reporting Person, Westphal, Longwood II GP and Longwood Management disclaims beneficial ownership of the shares held by Longwood II and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
/s/ Richard Aldrich
2017-10-19